A randomized blind trial of Iopamidol (Niopam) and Metrizamide (Amipaque) in lumber radiculography

1 February 1983

journal article
research article
Published by Springer Nature in Neuroradiology

Vol. 24 (4) , 217-218
https://doi.org/10.1007/bf00399774

Abstract

A randomised blind trial comparing Iopamidol (Niopam) and Metrizamide (Amipaque) for lumbar radiculography was performed in 100 patients. Significantly more patients receiving Metrizamide complained of having severe headaches (PP<0.05). There was no difference in quality of the radiculograms.

Keywords

RADICULOGRAPHY
RANDOMISED BLIND TRIAL
IOPAMIDOL (NIOPAM) METRIZAMIDE (AMIPAQUE)
SIDE EFFECTS

This publication has 4 references indexed in Scilit:

Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology
Neuroradiology, 1980
Sequelae of metrizamide myelography in 200 examinations
American Journal of Roentgenology, 1978
Metrizamide—CSF Contrast Medium
Radiology, 1977
Lumbar myelography with metrizamide—a new non-ionic contrast medium
The British Journal of Radiology, 1976